Teladoc Accounts Payable vs Short Term Debt Analysis
TDOC Stock | USD 11.43 0.06 0.53% |
Teladoc financial indicator trend analysis is much more than just breaking down Teladoc prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Teladoc is a good investment. Please check the relationship between Teladoc Accounts Payable and its Short Term Debt accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Teladoc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. For information on how to trade Teladoc Stock refer to our How to Trade Teladoc Stock guide.
Accounts Payable vs Short Term Debt
Accounts Payable vs Short Term Debt Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Teladoc Accounts Payable account and Short Term Debt. At this time, the significance of the direction appears to have strong relationship.
The correlation between Teladoc's Accounts Payable and Short Term Debt is 0.65. Overlapping area represents the amount of variation of Accounts Payable that can explain the historical movement of Short Term Debt in the same time period over historical financial statements of Teladoc, assuming nothing else is changed. The correlation between historical values of Teladoc's Accounts Payable and Short Term Debt is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Accounts Payable of Teladoc are associated (or correlated) with its Short Term Debt. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Short Term Debt has no effect on the direction of Accounts Payable i.e., Teladoc's Accounts Payable and Short Term Debt go up and down completely randomly.
Correlation Coefficient | 0.65 |
Relationship Direction | Positive |
Relationship Strength | Significant |
Accounts Payable
An accounting item on the balance sheet that represents Teladoc obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Teladoc are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.Short Term Debt
Most indicators from Teladoc's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Teladoc current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Teladoc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. For information on how to trade Teladoc Stock refer to our How to Trade Teladoc Stock guide.At present, Teladoc's Enterprise Value Over EBITDA is projected to increase significantly based on the last few years of reporting. The current year's Enterprise Value Multiple is expected to grow to 27.02, whereas Selling General Administrative is forecasted to decline to about 236 M.
2021 | 2022 | 2023 | 2024 (projected) | Interest Expense | 80.4M | 9.3M | 22.3M | 25.1M | Depreciation And Amortization | 219.6M | 270.6M | 351.3M | 368.9M |
Teladoc fundamental ratios Correlations
Click cells to compare fundamentals
Teladoc Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Teladoc fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 1.6B | 17.8B | 17.7B | 4.3B | 4.4B | 4.9B | |
Short Long Term Debt Total | 465.4M | 1.5B | 1.3B | 1.6B | 1.6B | 1.7B | |
Other Current Liab | 63.6M | 178.6M | 169.1M | 324.5M | 257.0M | 269.9M | |
Total Current Liabilities | 90.2M | 332.6M | 331.0M | 399.8M | 420.6M | 441.6M | |
Total Stockholder Equity | 1.0B | 15.9B | 16.0B | 2.3B | 2.3B | 4.0B | |
Other Liab | 33.2M | 106.2M | 81.1M | 56.4M | 64.9M | 38.6M | |
Property Plant And Equipment Net | 36.7M | 75.2M | 74.0M | 71.5M | 72.1M | 36.4M | |
Net Debt | (48.9M) | 732.0M | 374.0M | 655.1M | 468.6M | 492.0M | |
Retained Earnings | (507.5M) | (992.7M) | (1.4B) | (15.0B) | (15.2B) | (14.5B) | |
Accounts Payable | 9.1M | 46.0M | 47.3M | 47.7M | 43.6M | 45.8M | |
Cash | 514.4M | 733.3M | 893.5M | 918.2M | 1.1B | 1.2B | |
Non Current Assets Total | 1.0B | 16.7B | 16.5B | 3.0B | 2.9B | 4.2B | |
Non Currrent Assets Other | 6.5M | 18.4M | 20.7M | 48.5M | 80.3M | 84.3M | |
Other Assets | 6.5M | 2.1K | 20.7M | 48.5M | 55.8M | 58.6M | |
Long Term Debt | 440.4M | 1.4B | 1.2B | 1.5B | 1.5B | 1.6B | |
Cash And Short Term Investments | 517.1M | 786.6M | 896.0M | 918.2M | 1.1B | 1.2B | |
Net Receivables | 56.9M | 169.3M | 169.0M | 210.6M | 230.1M | 241.6M | |
Good Will | 746.1M | 14.6B | 14.5B | 1.1B | 1.2B | 1.2B | |
Common Stock Total Equity | 73K | 150K | 160K | 163K | 146.7K | 291.3K | |
Common Stock Shares Outstanding | 71.8M | 90.5M | 156.9M | 161.5M | 164.6M | 88.4M | |
Liabilities And Stockholders Equity | 1.6B | 17.8B | 17.7B | 4.3B | 4.4B | 4.9B | |
Non Current Liabilities Total | 498.6M | 1.5B | 1.4B | 1.6B | 1.6B | 1.7B | |
Other Current Assets | 14.0M | 94.5M | 87.4M | 130.3M | 105.8M | 111.1M | |
Other Stockholder Equity | 1.5B | 16.9B | 17.5B | 17.4B | 17.6B | 18.5B | |
Total Liab | 588.8M | 1.9B | 1.7B | 2.0B | 2.1B | 2.2B | |
Property Plant And Equipment Gross | 36.7M | 75.2M | 74.0M | 71.5M | 131.8M | 138.4M | |
Total Current Assets | 588.0M | 1.1B | 1.2B | 1.3B | 1.5B | 1.6B | |
Accumulated Other Comprehensive Income | (17.2M) | 18.5M | (6.3M) | (42.8M) | (37.0M) | (35.1M) | |
Intangible Assets | 225.5M | 2.0B | 1.9B | 1.8B | 1.7B | 1.8B | |
Common Stock | 73K | 150K | 160K | 163K | 167K | 276.9K | |
Property Plant Equipment | 10.3M | 28.6M | 74.0M | 29.6M | 34.1M | 19.4M | |
Net Tangible Assets | 67.5M | (665.2M) | (368.7M) | (556.1M) | (500.5M) | (475.5M) | |
Current Deferred Revenue | 12.5M | 52.4M | 75.6M | 90.5M | 95.7M | 100.4M | |
Short Term Investments | 79.5M | 54.5M | 2.7M | 53.2M | 2.5M | 0.0 | |
Deferred Long Term Liab | 21.7M | 104.6M | 2.4M | 54.8M | 63.0M | 66.2M | |
Short Term Debt | 5.1M | 54.0M | 26M | 13.6M | 10.8M | 15.8M | |
Retained Earnings Total Equity | (507.5M) | (992.7M) | (1.4B) | (15.0B) | (13.5B) | (12.8B) | |
Long Term Debt Total | 440.4M | 1.4B | 1.2B | 1.5B | 1.8B | 1.9B | |
Capital Surpluse | 1.5B | 16.9B | 17.5B | 17.4B | 20.0B | 21.0B |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Teladoc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Teladoc's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Teladoc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Teladoc Stock:Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Teladoc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. For information on how to trade Teladoc Stock refer to our How to Trade Teladoc Stock guide.You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Is Health Care Technology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Teladoc. If investors know Teladoc will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Teladoc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (5.78) | Revenue Per Share 15.333 | Quarterly Revenue Growth (0.03) | Return On Assets (0.03) | Return On Equity (0.52) |
The market value of Teladoc is measured differently than its book value, which is the value of Teladoc that is recorded on the company's balance sheet. Investors also form their own opinion of Teladoc's value that differs from its market value or its book value, called intrinsic value, which is Teladoc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Teladoc's market value can be influenced by many factors that don't directly affect Teladoc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Teladoc's value and its price as these two are different measures arrived at by different means. Investors typically determine if Teladoc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Teladoc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.